---
title: "SEEL.US (SEEL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SEEL.US/news.md"
symbol: "SEEL.US"
name: "SEEL.US"
parent: "https://longbridge.com/en/quote/SEEL.US.md"
datetime: "2026-05-21T13:17:05.974Z"
locales:
  - [en](https://longbridge.com/en/quote/SEEL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SEEL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SEEL.US/news.md)
---

# SEEL.US (SEEL.US) — Related News

### [Psychiatry Drug Maker Seaport Therapeutics Jumps 10% in U.S. IPO Debut](https://longbridge.com/en/news/284946947.md)
*2026-05-01T23:09:58.000Z*
> Boston-based biotech company Seaport Therapeutics Inc. (SPTX) raised nearly $255 million in its initial public offering 

### [The IPO Buzz: Seaport Therapeutics Increases IPO’s Size & Prices it at $18 – Top of Range](https://longbridge.com/en/news/284896142.md)
*2026-05-01T12:00:58.000Z*
> Seaport Therapeutics (SPTX), a Boston-based biotech, has increased its IPO size to 14.16 million shares, priced at $18.0

### [](https://longbridge.com/en/news/284851728.md)
*2026-05-01T00:01:02.000Z*
> Seaport Therapeutics reportedly raised $255 million in its initial public offering to scale up

### [Avalyn Announces Pricing of Upsized Initial Public Offering](https://longbridge.com/en/news/284671903.md)
*2026-04-30T01:00:00.000Z*
> On April 29, 2026, Avalyn Pharma Inc. announced the pricing of its upsized initial public offering, consisting of 16,666

### [Seaport and Hemab target $180m IPOs as biotech listings accumulate](https://longbridge.com/en/news/284375788.md)
*2026-04-28T10:22:38.000Z*
> A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings.

### [Neuropsychiatric drug developer SeaportIPO prices at $16-18 per share, aiming to raise $201 million](https://longbridge.com/en/news/284339355.md)
*2026-04-28T09:02:33.000Z*
> Biotechnology company Seaport Therapeutics, focused on developing therapies for neuropsychiatric disorders, announced it

### [Seaport, Hemab launch US IPOs as biotech listings gather momentum](https://longbridge.com/en/news/284221810.md)
*2026-04-27T13:03:18.000Z*
> April 27 (Reuters) - Drug developers Seaport Therapeutics and Hemab Therapeutics launched their U.S. initial public offe